| D007070 |
Immunoglobulin A |
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. |
IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA |
|
| D007074 |
Immunoglobulin G |
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. |
Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin |
|
| D010051 |
Ovarian Neoplasms |
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. |
Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm |
|
| D005260 |
Female |
|
Females |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D001323 |
Autoantibodies |
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. |
Autoantibody |
|
| D013724 |
Teratoma |
A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642) |
Dysembryoma,Teratoid Tumor,Teratoma, Cystic,Teratoma, Mature,Teratoma, Benign,Teratoma, Immature,Teratoma, Malignant,Benign Teratoma,Benign Teratomas,Dysembryomas,Immature Teratoma,Immature Teratomas,Malignant Teratoma,Malignant Teratomas,Teratoid Tumors,Teratomas,Teratomas, Benign,Teratomas, Immature,Teratomas, Malignant,Tumor, Teratoid,Tumors, Teratoid |
|
| D016194 |
Receptors, N-Methyl-D-Aspartate |
A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. |
N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate |
|
| D042601 |
Lymphatic Vessels |
Tubular vessels that are involved in the transport of LYMPH and LYMPHOCYTES. |
Capillaries, Lymphatic,Lymphatic Capillaries,Lymphatic Venules,Venules, Lymphatic,Capillary, Lymphatic,Lymphatic Capillary,Lymphatic Venule,Lymphatic Vessel,Venule, Lymphatic,Vessel, Lymphatic,Vessels, Lymphatic |
|
| D060426 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis |
Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies. |
Anti-NMDA Receptor Encephalitis,Anti-NMDAR Encephalitis,Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis,Non-paraneoplastic Anti-NMDA Receptor Encephalitis,Non-paraneoplastic Anti-NMDAR Encephalitis,Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis,Paraneoplastic Anti-NMDA Receptor Encephalitis,Paraneoplastic Anti-NMDAR Encephalitis,Anti N Methyl D Aspartate Receptor Encephalitis,Anti NMDA Receptor Encephalitis,Anti NMDAR Encephalitis,Anti-N-Methyl-D-Aspartate Receptor Encephalitides,Anti-NMDA Receptor Encephalitides,Anti-NMDAR Encephalitides,Anti-NMDAR Encephalitides, Non-paraneoplastic,Anti-NMDAR Encephalitides, Paraneoplastic,Anti-NMDAR Encephalitis, Non-paraneoplastic,Anti-NMDAR Encephalitis, Paraneoplastic,Encephalitides, Anti-N-Methyl-D-Aspartate Receptor,Encephalitides, Anti-NMDA Receptor,Encephalitides, Anti-NMDAR,Encephalitides, Non-paraneoplastic Anti-NMDAR,Encephalitides, Paraneoplastic Anti-NMDAR,Encephalitis, Anti-N-Methyl-D-Aspartate Receptor,Encephalitis, Anti-NMDA Receptor,Encephalitis, Anti-NMDAR,Encephalitis, Non-paraneoplastic Anti-NMDAR,Encephalitis, Paraneoplastic Anti-NMDAR,Non paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis,Non paraneoplastic Anti NMDA Receptor Encephalitis,Non paraneoplastic Anti NMDAR Encephalitis,Non-paraneoplastic Anti-NMDAR Encephalitides,Paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis,Paraneoplastic Anti NMDA Receptor Encephalitis,Paraneoplastic Anti NMDAR Encephalitis,Paraneoplastic Anti-NMDAR Encephalitides,Receptor Encephalitides, Anti-NMDA,Receptor Encephalitis, Anti-NMDA |
|